SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ARRIS - Another partner
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
353 2 0 AXPH
Emcee:  Paul Getman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
178 I agree that from the angle you have presented, ARRS isn't going anywhere fCYBERKEN-9/28/1997
177 Arrs has a problem in that there are numerous decent treatments for Asthma and Howard Henick-9/28/1997
176 PB: Thanks for info. These small uncontrolled studies provide little informatDavid Bogdanoff-9/26/1997
175 David, Lehman Brothers has put a brief update on Arris in their web page lehmanPseudo Biologist-9/26/1997
174 PB: The second generation tryptase ihibitor development is unknown to me. I haDavid Bogdanoff-9/26/1997
173 David, no kidding about SF Bay Area real estate and the requirement for a "Pseudo Biologist-9/26/1997
172 PB: I read a book years ago on the importance to a company of getting and keepDavid Bogdanoff-9/26/1997
171 David, you make some good points but when you write "low stock prices are Pseudo Biologist-9/26/1997
170 SELL into strength; BUY into weakness So easy to say and diificult for many toVFib911911-9/26/1997
169 CY: I agree that there has been a dearth of information coming out of the compDavid Bogdanoff-9/26/1997
168 You see so many biotechs with good management grossly mismanaging these types oCYBERKEN-9/26/1997
167 Arris is off this morning, as expected. I have a hard time why this study was David Bogdanoff-9/25/1997
166 I'm missing something here. I attended an investor conference in July whereLarry Liebman-9/25/1997
165 Thanks James! I was looking forward to initiate again my position on ARRS. AftMiljenko Zuanic-9/24/1997
164 Sounds like a buying opprtunity is about to present itself----The lower the betVFib911911-9/24/1997
163 MZ, Agree with you. Personally I would be pleased if they dropped developmentJames Silverman-9/24/1997
162 To me news and results sound ambiguous. Short and non-defined. This is second tMiljenko Zuanic-9/24/1997
161 I hate to see any of them drop, but unlike AMLN, where I ran like hell (one proCYBERKEN-9/24/1997
160 >>Statistical significance requires a greater sample size than is usuallyAndrew H-9/24/1997
159 I managed to listen to most of a 1:30 conference call and digested the followinLarry Liebman-9/24/1997
158 AH; I don't view this news as automatically negative. PhaseII trials are David Bogdanoff-9/24/1997
157 Thanks Andrew (for the posting not for the regrets as I have been out of this oPseudo Biologist-9/24/1997
156 Just heard about it on CNN. Regrets to shareholders. However, they came close-Andrew H-9/24/1997
155 The release just made it to yahoo: biz.yahoo.com PBPseudo Biologist-9/24/1997
154 Just heard on CNBC from Joe Kernin. Arris announced results of an asthma studyDavid Bogdanoff-9/24/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News